Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;48(4):272-4.
doi: 10.1016/j.aprim.2015.07.004. Epub 2015 Oct 29.

[Intervention in the prescribing of the combination of an angiotensin converting enzyme inhibitor and an angiotensin-II receptor blocker]

[Article in Spanish]
Alfredo Portilla  1 , Daniel Torres  1 , Manuel Enrique Machado-Duque  2 , Jorge Enrique Machado-Alba  3
Affiliations

[Intervention in the prescribing of the combination of an angiotensin converting enzyme inhibitor and an angiotensin-II receptor blocker]

[Article in Spanish]
Alfredo Portilla et al. Aten Primaria. 2016 Apr.
No abstract available

PubMed Disclaimer

Figures

Figura 1
Figura 1
Tendencia de consumo promedio mensual de inhibidores del sistema renina-angiotensina-aldosterona (IECA o BRA-II) y tendencia de prescripciones de co-prescripción IECA + BRA-II en 2 EPS de la ciudad de Bogotá, Colombia. 2010–2014.
See this image and copyright information in PMC

References

    1. James P.A., Oparil S., Carter B.L., Cushman W.C., Dennison-Himmelfarb C., Handler J. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA. 2014;311:507–520. - PubMed
    1. Chrysant S.G. Current status of dual renin angiotensin aldosterone system blockade for the treatment of cardiovascular diseases. Am J Cardiol. 2010;105:849–852. - PubMed
    1. Holdiness A., Monahan K., Minor D., de Shazo R.D. Renin angiotensin aldosterone system blockade: Little to no rationale for ACE inhibitor and ARB combinations. Am J Med. 2011;124:15–19. - PubMed
    1. Werner C., Baumhäkel M., Teo K.K., Schmieder R., Mann J., Unger T. RAS blockade with ARB and ACE inhibitors: Current perspective on rationale and patient selection. Clin Res Cardiol. 2008;97:418–431. - PubMed
    1. Machado-Alba J.E., Giraldo-Giraldo C., Machado-Duque M.E. Quality of conventional release verapamil prescription in patients with arterial hypertension. Rev Calid Asist. 2015;30:72–78. - PubMed

MeSH terms

Substances